权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Reactive Oxygen Species in Coronary Collateral Growth

冠状动脉侧枝生长中的活性氧

基本信息

批准号：
8471748
负责人：
WILLIAM M CHILIAN
金额：
$ 44.72万
依托单位：
NORTHEAST OHIO MEDICAL UNIVERSITY
依托单位国家：
美国
项目类别：
财政年份：
2009
资助国家：
美国
起止时间：
2009-07-22 至 2015-05-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/8471748
关键词：
Abbreviations Adenoviruses Animal Model Animals Anterior Descending Coronary Artery Antioxidants Arginine Binding Biology Blood Vessels Bypass Canis familiaris Cardiac Myocytes Cardiac Myosins Cardiovascular system Cause of Death Cells Chronic Collateral Circulation Coronary Data Dependency Development Disease Dominant-Negative Mutation Dyslipidemias Electroporation Endothelial Cells Endothelium Environment Event Foundations Glossary Goals Growth Growth Factor Health Healthcare Systems Heart Hydrogen Peroxide Hyperglycemia Hyperlipidemia Hypertension Impairment Incidence Infarction Insulin Resistance Investigation Ischemia Laboratories Left Link Location MAP Kinase Gene MAPK14 gene Measurement Mediator of activation protein Metabolic syndrome Modeling Morbidity - disease rate Mutate Myocardial Myocardial Ischemia Myocardium Myosin Heavy Chains NF-E2-related factor 2 Obesity Oxidation-Reduction Oxidative Stress Pathology Patients Plasmid Cloning Vector Plasmids Problem Solving Production Protocols documentation Rattus Reactive Oxygen Species Reperfusion Therapy Reporting Response Elements Risk Factors Signal Pathway Signal Transduction Smooth Muscle Smooth Muscle Myocytes Specificity Sudden Death Sulfhydryl Compounds Techniques Testing United States Vascular Diseases base cadherin 5 cell type cost dihydroethidium enhanced green fluorescent protein falls gene therapy human MAPK14 protein in vivo insight mitogen-activated protein kinase p38 mortality mutant nuclear factor-erythroid 2 outcome forecast oxidation prevent promoter protein activation protein expression research study response vector viral vector development

项目摘要

DESCRIPTION (provided by applicant): Results from our and other laboratories demonstrate that a critical amount of ROS and a redox state within a certain boundary is critical for coronary collateral growth; however, oxidative stress, i.e., a shift in the redox state to a more oxidative environment, impairs coronary collateral growth. Previous investigations fall short of ascertaining the cell type (or types), in which alterations of redox state matter, and where redox signaling is critical. The overarching goal of this proposal is to determine the cell type or types in the heart responsible for redox signaling in the growth of the coronary collateral circulation in response to repetitive ischemia. A corollary to this aim is that we will also determine the cell type or types in which oxidative stress confers negative influences on coronary collateral growth. To solve these problems we propose the following specific aims: Aim 1. Determine in which cell type (or types) does oxidative stress corrupt coronary collateral growth. We will induce oxidative stress in the coronary endothelium, smooth muscle cells and cardiac myocytes using the cell-specific promoters VE-Cadherin, SM22, and cardiac myosin heavy chain (CMHC), respectively. Cells will be transfected with a plasmid (using in vivo electroporation) or transduced with an adenovirus expressing an iNOS mutant (E371A) that does not bind arginine, and therefore, only produces O2. Aim 2. Determine in which cell type (or types) the redox sensitive p38 MAPK is critical for coronary collateral growth. We will transfect or transduce coronary endothelium, smooth muscle cells and cardiac myocytes using cell-specific promoters described for Aim 1 using a vector expressing a dominant/negative p38 MAPK (DNp38). After determining the particular cell type in the heart most sensitive to the effects of oxidative stress and redox signaling in coronary collateral growth, we will extend our findings to an animal model of vascular pathology (the JCR rat: a model of the metabolic syndrome), which demonstrates poor coronary collateral growth. Specifically in the final two aims we will: Aim 3. Determine the cell type where reducing oxidative stress by over expressing Nrf2 in the JCR rat (a model of reduced coronary collateral growth and oxidative stress) will restore collateral growth. Aim 4. Determine the cell type where expression of a constitutively active p38 MAP kinase will restore collateral growth in the JCR rat. The proposed studies employ a multifaceted approach to solving cell-specific signaling in vivo by employing techniques to determine cell specific changes in protein expression, thiol oxidation and ROS production and ultimately linking these measurements to coronary collateral growth. These studies will provide insight into the cell-specific locations where ROS and redox signaling modulate coronary collateral growth.

描述(由申请人提供)：我们和其他实验室的结果表明，在特定边界内的临界量的ROS和氧化还原状态对冠状动脉侧枝生长至关重要；然而，氧化应激，即从氧化还原状态转变到更氧化的环境，会损害冠脉侧枝生长。以前的研究没有确定细胞类型，在这些类型中，氧化还原状态的改变是重要的，而氧化还原信号是关键的。这项建议的首要目标是确定心脏中负责氧化还原信号的一个或多个细胞类型，这些细胞在冠脉侧支循环的增长中对反复缺血做出反应。这一目标的必然结果是，我们还将确定氧化应激对冠状动脉侧枝生长产生负面影响的一个或多个细胞类型。为了解决这些问题，我们提出了以下具体目标：目的1.确定氧化应激在哪种细胞类型(或哪几种类型)中破坏冠状动脉侧枝生长。我们将分别使用细胞特异性启动子VE-钙粘附素、SM22和心肌肌球蛋白重链(CMHC)诱导冠状动脉内皮细胞、平滑肌细胞和心肌细胞的氧化应激。细胞将被导入(使用体内电穿孔)质粒或转导表达iNOS突变体(E371a)的腺病毒，该突变体不结合精氨酸，因此只产生O2。目的2.确定氧化还原敏感的p38MAPK在哪种细胞类型(或几种类型)中对冠状动脉侧枝生长至关重要。我们将使用针对目标1的细胞特异性启动子，利用表达显性/阴性p38MAPK(DNp38)的载体，对冠状动脉内皮细胞、平滑肌细胞和心肌细胞进行转基因或转导。在确定了心脏中对氧化应激和氧化还原信号在冠脉侧支生长中的影响最敏感的特定细胞类型之后，我们将把我们的发现扩展到血管病理的动物模型(JCR大鼠：代谢综合征的模型)，该模型显示冠脉侧支生长不良。具体地说，在最后两个目标中，我们将：目标3.确定通过过度表达Nrf2在JCR大鼠(冠状动脉侧支生长和氧化应激减少的模型)中减少氧化应激将恢复侧支生长的细胞类型。目的4.确定在JCR大鼠中，表达具有结构性活性的p38MAPK将恢复侧枝生长的细胞类型。这项拟议的研究采用了一种多方面的方法来解决体内细胞特异的信号传递问题，方法是使用技术来确定蛋白质表达、硫醇氧化和ROS产生的细胞特异性变化，并最终将这些测量与冠状动脉侧支生长联系起来。这些研究将深入了解ROS和氧化还原信号调节冠脉侧支生长的细胞特异性位置。

项目成果

期刊论文数量（2）

专著数量（0）

科研奖励数量（0）

会议论文数量（0）

专利数量（0）

Novel thiazolidinedione mitoNEET ligand-1 acutely improves cardiac stem cell survival under oxidative stress.

DOI：
10.1007/s00395-015-0471-z
发表时间：
2015-03
期刊：
Basic research in cardiology
影响因子：
9.5
作者：
Logan SJ;Yin L;Geldenhuys WJ;Enrick MK;Stevanov KM;Carroll RT;Ohanyan VA;Kolz CL;Chilian WM
通讯作者：
Chilian WM

A brief etymology of the collateral circulation.